Transient beneficial effects of glutamate-aspartate-enriched cardioplegia on ventricular functions in coronary artery bypass grafting.
Duman
Umit
U
Dogan
Omer Faruk
OF
D001224:Aspartic Acid / Q000627:therapeutic use*; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D018698:Glutamic Acid / Q000627:therapeutic use*; D006801:Humans; D013318:Stroke Volume / Q000187:drug effects; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology / Q000517:prevention & control*; D016277:Ventricular Function, Left / Q000187:drug effects
D002314:Cardioplegic Solutions; D001224:Aspartic Acid; D018698:Glutamic Acid